Literature DB >> 34014396

Predicting financial deficits from a standard neuropsychological assessment: preliminary evidence in mild cognitive impairment.

Francesca Burgio1, Silvia Benavides-Varela2,3, Roberta Toffano4, Katie Palmer5, Francesca Meneghello4, Giorgio Arcara4, Carlo Semenza4,6.   

Abstract

Patients with mild cognitive impairment (MCI) might experience difficulties in numerical and financial abilities of daily living that compromise their autonomy. The aim of the present work was to examine whether specific tests of the standard neuropsychological assessment could be used to predict these deficits in the clinical practice. Thirty-four MCI patients underwent a comprehensive clinical and neuropsychological examination including (1) a complete assessment of financial abilities and (2) a traditional neuropsychological assessment including measures of language, memory, executive functioning, reasoning, attention, and visuospatial abilities. The neuropsychological tests were used as predictors of the performance in everyday financial tasks using logistic regression analysis. Deficits in financial tasks including calculating percentages, using financial concepts and applying financial judgments were significantly predicted by tests of executive functions, language and short-term memory, while deficits in frequently encountered financial tasks activities such as item purchase and reading numbers could not be predicted by standard neuropsychological evaluations. Contingency tables on performance above/below clinical cut-offs evidenced some cases of financial deficits in the absence of cognitive deficits and, vice versa, some patients with cognitive decline did not show financial impairments. These results suggest that while some cognitive functions might be crucial for taking financial decisions, an ad hoc test of financial capacity is essential to make overall inferences about the everyday financial autonomy of MCI patients. This has potential implications for clinical and legal decisions that directly impact the individuals and their families.
© 2021. Fondazione Società Italiana di Neurologia.

Entities:  

Keywords:  Financial abilities; IADL; Legal practice; MCI; Neuropsychological assessment

Mesh:

Year:  2021        PMID: 34014396     DOI: 10.1007/s10072-021-05304-0

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.830


  12 in total

Review 1.  Mild cognitive impairment.

Authors:  Serge Gauthier; Barry Reisberg; Michael Zaudig; Ronald C Petersen; Karen Ritchie; Karl Broich; Sylvie Belleville; Henry Brodaty; David Bennett; Howard Chertkow; Jeffrey L Cummings; Mony de Leon; Howard Feldman; Mary Ganguli; Harald Hampel; Philip Scheltens; Mary C Tierney; Peter Whitehouse; Bengt Winblad
Journal:  Lancet       Date:  2006-04-15       Impact factor: 79.321

2.  Anatomical substrates and neurocognitive predictors of daily numerical abilities in mild cognitive impairment.

Authors:  Silvia Benavides-Varela; Francesca Burgio; Francesca Meneghello; Matteo De Marco; Giorgio Arcara; Jessica Rigon; Cristina Pilosio; Brian Butterworth; Annalena Venneri; Carlo Semenza
Journal:  Cortex       Date:  2015-06-18       Impact factor: 4.027

3.  Effects of age and mild cognitive impairment on direct and indirect access to arithmetic knowledge.

Authors:  L Zamarian; E Stadelmann; H-C Nürk; N Gamboz; J Marksteiner; M Delazer
Journal:  Neuropsychologia       Date:  2006-12-27       Impact factor: 3.139

4.  Effects of Healthy Aging and Mild Cognitive Impairment on a Real-Life Decision-Making Task.

Authors:  Marie-Theres Pertl; Thomas Benke; Laura Zamarian; Margarete Delazer
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

5.  Cognitive correlates of financial abilities in mild cognitive impairment.

Authors:  Ozioma C Okonkwo; Virginia G Wadley; H Randall Griffith; Karlene Ball; Daniel C Marson
Journal:  J Am Geriatr Soc       Date:  2006-11       Impact factor: 5.562

6.  Assessing financial capacity in patients with Alzheimer disease: A conceptual model and prototype instrument.

Authors:  D C Marson; S M Sawrie; S Snyder; B McInturff; T Stalvey; A Boothe; T Aldridge; A Chatterjee; L E Harrell
Journal:  Arch Neurol       Date:  2000-06

7.  Impaired financial abilities in mild cognitive impairment: a direct assessment approach.

Authors:  H R Griffith; K Belue; A Sicola; S Krzywanski; E Zamrini; L Harrell; D C Marson
Journal:  Neurology       Date:  2003-02-11       Impact factor: 9.910

8.  MRI volume of the medial frontal cortex predicts financial capacity in patients with mild Alzheimer's disease.

Authors:  Luke E Stoeckel; Christopher C Stewart; H Randall Griffith; Kristen Triebel; Ozioma C Okonkwo; Jan A den Hollander; Roy C Martin; Katherine Belue; Jacquelynn N Copeland; Lindy E Harrell; John C Brockington; David G Clark; Daniel C Marson
Journal:  Brain Imaging Behav       Date:  2013-09       Impact factor: 3.978

9.  Numerical Activities of Daily Living - Financial (NADL-F): A tool for the assessment of financial capacities .

Authors:  Giorgio Arcara; Francesca Burgio; Silvia Benavides-Varela; Roberta Toffano; Patrizia Gindri; Elisabetta Tonini; Francesca Meneghello; Carlo Semenza
Journal:  Neuropsychol Rehabil       Date:  2017-09-07       Impact factor: 2.868

10.  The role of limbic structures in financial abilities of mild cognitive impairment patients.

Authors:  Silvia Benavides-Varela; Francesca Burgio; Luca Weis; Micaela Mitolo; Katie Palmer; Roberta Toffano; Giorgio Arcara; Antonino Vallesi; Dante Mantini; Francesca Meneghello; Carlo Semenza
Journal:  Neuroimage Clin       Date:  2020-02-19       Impact factor: 4.881

View more
  2 in total

1.  Financial Decision-Making in Neurological Patients.

Authors:  Laura Danesin; Andreina Giustiniani; Giorgio Arcara; Francesca Burgio
Journal:  Brain Sci       Date:  2022-04-21

2.  Numerical activities of daily living: a short version.

Authors:  Francesca Burgio; Laura Danesin; Silvia Benavides-Varela; Francesca Meneghello; Brian Butterworth; Giorgio Arcara; Carlo Semenza
Journal:  Neurol Sci       Date:  2021-06-23       Impact factor: 3.307

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.